Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cassava Sciences Inc SAVA

Healthcare
Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on neuroscience. The Company's science is based on stabilizing, but not removing, a critical protein in the Alzheimer’s brain. Its scientific approach for the treatment of Alzheimer's disease seeks to simultaneously suppress both neurodegeneration and neuroinflammation. It has two biopharmaceutical assets under... see more

Recent & Breaking News (NDAQ:SAVA)

Pain Therapeutics Resumes Responsibility for REMOXY

GlobeNewswire April 21, 2015

Pain Therapeutics Reports FY 2014 Financial Results

GlobeNewswire February 17, 2015

Pain Therapeutics Reports Q3 2014 Financial Results

GlobeNewswire October 30, 2014

DURECT Provides Update on REMOXY® and POSIDUR(TM) Programs

PR Newswire October 27, 2014

Pain Therapeutics to Regain Full Rights to REMOXY(R)

GlobeNewswire October 27, 2014

Pain Therapeutics to Host Conference Call to Discuss Q3 2014 Financial Results

GlobeNewswire October 23, 2014

Pain Therapeutics Expands Pipeline With FENROCK(TM), an Abuse-Deterrent Pain Patch

GlobeNewswire September 26, 2014

Pain Therapeutics to Present at the BioCentury NewsMakers Conference on Friday, September 26th

GlobeNewswire September 17, 2014

Pain Therapeutics (PTIE) Drops 8.05% on September 3

Equities.com September 3, 2014

Pain Therapeutics (PTIE) Jumps 5.92% on September 2

Equities.com September 2, 2014

Leading Health Care Stock for Small-Cap Stars is Inovio Pharmaceuticals Inc. (INO) for August 21

Equities.com August 21, 2014

Pain Therapeutics Reports Q2 2014 Financial Results

GlobeNewswire August 5, 2014

Pain Therapeutics to Host Conference Call to Discuss Q2 2014 Financial Results

GlobeNewswire July 30, 2014

Pain Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference

GlobeNewswire May 27, 2014

Pain Therapeutics to Present at the Bank of America Merrill Lynch 2014 Health Care Conference

GlobeNewswire May 8, 2014

Pain Therapeutics Reports Q1 2014 Financial Results

GlobeNewswire May 6, 2014

Pain Therapeutics to Host Conference Call to Discuss Q1 2014 Financial Results

GlobeNewswire April 30, 2014

Theralase Could Light Up Cancer Therapeutics

Accesswire April 24, 2014

Pain Therapeutics Invited to Present at 26th Annual ROTH Conference

GlobeNewswire March 6, 2014

Pain Therapeutics Invited to Present at Cowen Health Care Conference in Boston

GlobeNewswire February 25, 2014